Jess Lonner, MD
Orthopaedic Surgery · Bryn Mawr, PANPI 1568499309
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $6,934,167 of the $7,803,388 with a category attached, or 88.9%. Zimmer Biomet accounts for 92.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $3,627,929 and has fallen 80.7% since, to $698,854 in 2025. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 463 payments — averaging $16,854 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$7.2M
- Smith+Nephew$588K
- Pacira Pharmaceuticals Incorporated$13K
- Heraeus Medical, LLC.$25
- Johnson & Johnson$15
Across 33 payments — averaging $10,626 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$304K
- Smith+Nephew$46K
What the payments were for
- Royalty or licence$6,934,16789%
- Consulting fees$668,5389%
- Speaking & faculty fees$1,6600%
- Travel & lodging$48,8361%
- Food & beverage$7,2480%
- Education$112,1881%
- Other$30,7520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 380 | $7,202,721 |
| Smith+Nephew | 70 | $587,894 |
| Pacira Pharmaceuticals Incorporated | 8 | $12,732 |
| Heraeus Medical, LLC. | 4 | $25 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$6,412,435
- Journey II$427,902
- STRIDE UNI$152,604
- Stride Unicondylar Knee System$129,372
- ROSA$107,309
- Persona Revision$106,499
- NAVIO$30,752
- PD-Knee-New Product$25,755
- STRIDE$23,153
- Rosa PKA$15,563
- mymobility Platform$15,000
- EXPAREL$12,080
- Journey II XR$9,477
- ZUK Uni$2,112
- Journey II BCS$1,660
- Navio Surgical System$1,660
- Oxford$1,618
- OSSEOTITE$875
- JOURNEY II UK$773
- JII Unicondylar Knee System$713
How this compares
$7,803,388 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 248 | $1,399 |
| Meloxicam | 210 | $547 |
| Celecoxib | 33 | $533 |
| Tramadol Hcl | 137 | $347 |
| Amoxicillin | 91 | $275 |
| Cyclobenzaprine Hcl | 22 | $192 |
| Ondansetron Hcl | 72 | $171 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $85 |
| Ciprofloxacin Hcl | 11 | $77 |
| Methylprednisolone | 13 | $64 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $50 |
| Ondansetron OdtOndansetron | 11 | $44 |
| Clindamycin Hcl | 19 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bryn Mawr
- Gerald WilliamsBryn Mawr$6.8M
- Yale FillinghamBryn Mawr$748K
- William HozackBensalem$10.6M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Alexander VaccaroPhiladelphia$4.5M
- Selene ParekhBensalem$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Jonathan GarinoMalvern$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.